Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05722132 · ClinicalTrials.gov registry record · NA
Latinos Kick Buts: Mobile Engagement and Cessation Support for Latinos Who Smoke
A NA study of Smoking Cessation, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 2,826
- Enrollment target
- 1
- Study location
NCT05722132: Completed NA study of Smoking Cessation, sponsored by University of Rochester.
NCT05722132 is a NA study of Smoking Cessation that has completed, run by University of Rochester. The registered enrollment target is 2,826 participants, above the 460-participant average among 188 other Smoking Cessation trials with a reported enrollment target (514% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05722132, a NA study of Smoking Cessation, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,826 participants
- Enrollment target
- 1
- Study location
Study Summary
Latino Kick Buts (LKB) is a smoking cessation treatment program available to Strong Memorial Hospital patients who smoke. LKB encompasses two integrated components: (1) a 12-week text messaging counseling program with interactive capabilities and (2) pharmacotherapy support (provision of nicotine replacement therapy at no cost). LKB utilization among Latinos who smoke remains minimal. This study aims to identify the types of text messages more effective in enrolling Latinos who smoke, identified in the electronic medical record, into LKB.
Conditions Studied
Interventions
- BEHAVIORAL One cycle
- BEHAVIORAL 4 cycles
- BEHAVIORAL 5 Dollar Incentive
- BEHAVIORAL Raffle Incentive
Study Locations (1)
New York
- University of Rochester Medical Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,826 participants |
| Start Date | 2022-12-27 |
| Est. Completion | 2023-03-25 |
| Phase | NA |
What the finished NCT05722132 record still lists
NCT05722132 is an interventional study that assigns participants to a tested intervention. Its 2,826 participants enrollment target places it among the larger protocols in the corpus, above the 460-participant average among 188 other Smoking Cessation trials with a reported enrollment target (514% higher).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 4 interventions - of which One cycle is the first listed.
NCT05722132 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05722132 about?
NCT05722132 is a clinical study titled "Latinos Kick Buts: Mobile Engagement and Cessation Support for Latinos Who Smoke". Latino Kick Buts (LKB) is a smoking cessation treatment program available to Strong Memorial Hospital patients who smoke. LKB encompasses two integrated components: (1) a 12-week text messaging counseling program with interactive capabilities and (2) pharmacotherapy support (provision of nicotine re...
What is the current status of trial NCT05722132?
This trial is currently completed. It is a NA study. The enrollment target is 2,826 participants. The study started on 2022-12-27. Estimated completion is 2023-03-25.
What conditions does trial NCT05722132 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT05722132?
The interventions under investigation include: One cycle (BEHAVIORAL), 4 cycles (BEHAVIORAL), 5 Dollar Incentive (BEHAVIORAL), Raffle Incentive (BEHAVIORAL).
Who is sponsoring clinical trial NCT05722132?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05722132 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05722132's enrollment target sits among peer trials
2,826 5th of 188 higher than 184 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02273297 · 2,821 participants
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
- NCT05932602 · 2,812 participants
AVEIR DR Coverage With Evidence Development (CED) Study
- NCT06150781 · 2,842 participants
Aimovig Pregnancy Exposure Registry
- NCT05443737 · 2,800 participants · Phase 3
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI